{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:21:18Z","timestamp":1779394878951,"version":"3.53.1"},"reference-count":15,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002814","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:25:30Z","timestamp":1558718730000},"page":"e1002814","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Predicting progression to active tuberculosis: A rate-limiting step on the path to elimination"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2396-246X","authenticated-orcid":true,"given":"Ajit","family":"Lalvani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-9971","authenticated-orcid":true,"given":"Luis C.","family":"Berrocal-Almanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8183-1110","authenticated-orcid":true,"given":"Alice","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (WHO). Global tuberculosis report 2018. 2018 [cited 2019 Mar 22]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274453\/9789241565646-eng.pdf?ua=1\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274453\/9789241565646-eng.pdf?ua=1<\/ext-link>."},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon-gamma release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study","volume":"18","author":"I Abubakar","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"23","key":"ref3","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"New Engl J Med"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis","volume":"380","author":"S Swindells","year":"2019","journal-title":"N Engl J Med"},{"key":"ref5","unstructured":"World Health Organization (WHO). Consensus meeting report: development of a target product profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease. Report no. WHO\/HTM\/TB\/2017.18 2018 [cited 2019 Mar 22]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/iris\/handle\/10665\/259176\" xlink:type=\"simple\">http:\/\/www.who.int\/iris\/handle\/10665\/259176<\/ext-link>."},{"key":"ref6","unstructured":"World Health Organization (WHO). Latent tuberculosis infection Updated and consolidated guidelines for programmatic management 2018. [cited 2019 Mar 22] Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/2018\/latent-tuberculosis-infection\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/2018\/latent-tuberculosis-infection\/en\/<\/ext-link>."},{"issue":"10035","key":"ref7","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"DE Zak","year":"2016","journal-title":"Lancet"},{"issue":"10057","key":"ref8","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/S0140-6736(16)32070-0","article-title":"Predicting tuberculosis risk","volume":"388","author":"SV Kik","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201711-2340OC","article-title":"Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis","volume":"197","author":"S Suliman","year":"2018","journal-title":"Am J Resp Crit Care Med"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3779","article-title":"Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response","volume":"1","author":"HC Warsinske","year":"2018","journal-title":"JAMA Netw Open"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tube.2017.11.009","article-title":"Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention","volume":"109","author":"A Fiore-Gartland","year":"2018","journal-title":"Tuberculosis"},{"key":"ref12","first-page":"362","article-title":"Revisiting the timetable of tuberculosis","author":"MA Behr","year":"2018","journal-title":"BMJ"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/infdis\/jix107","article-title":"Stratification of Latent Mycobacterium tuberculosis Infection by Cellular Immune Profiling","volume":"215","author":"A Halliday","year":"2017","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent <italic>Mycobacterium tuberculosis<\/italic> infection suppresses T-cell function","volume":"188","author":"N du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00140009","article-title":"Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection","volume":"36","author":"D Goletti","year":"2010","journal-title":"Eur Respir J"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:59:16Z","timestamp":1589021956000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002814","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]}}}